Andrew Dreyfus
DirectoratIronwood Pharmaceuticals· In proxies 2023–2025
Andrew Dreyfus sits on 2 public boards.
Boards1
- Ironwood PharmaceuticalsDirector · 8 yr on the boardIndependentCompensation and HR (Chair)—Paid as an executive
;}%20.st1{fill-rule:evenodd;clip-rule:evenodd;fill:%23666868;}%20.st2{fill:%2399C13C;}%20.st3{fill:%237A9E3F;}%20.st4{fill:%23BED63A;}%20.st5{fill:%23666868;}%3c/style%3e%3cg%3e%3cdefs%3e%3crect%20id='SVGID_1_'%20x='4.7'%20y='3.6'%20width='241.2'%20height='53'/%3e%3c/defs%3e%3cclipPath%20id='SVGID_00000066476568263475870400000002741637092662773422_'%3e%3cuse%20xlink:href='%23SVGID_1_'%20style='overflow:visible;'/%3e%3c/clipPath%3e%3cg%20id='Group_6'%20transform='translate(0%200)'%20style='clip-path:url(%23SVGID_00000066476568263475870400000002741637092662773422_);'%3e%3cpath%20id='Path_1'%20class='st1'%20d='M85.4,32.4c-0.8-0.9-1.9-1.5-3.1-1.6c-1.8,0-3.2,1.1-6,4.6v-4h-4.2v23.8h4.2V41%20c2.2-4,4-6.1,5.4-6.1c0.4,0,0.8,0.2,1.6,0.9l0.1,0.1L85.4,32.4L85.4,32.4z%20M95.7,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C107.4,36.3,102.2,30.7,95.7,30.7%20M95.7,52c-4,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S99.7,52,95.7,52%20M63.6,55.1h4.5V20.6h-4.5V55.1z%20M231.7,17v15.2c-1.6-1.1-3.5-1.6-5.5-1.5%20c-7,0-12.1,5.5-12.1,13.2c0,7,4.1,11.9,9.9,11.9c2.9,0,5.7-1.3,7.6-3.4v2.7h4.2V17H231.7z%20M231.7,47.8c-0.7,0.9-1.5,1.8-2.5,2.5%20c-1.3,1-2.9,1.5-4.5,1.6c-3.6,0-6.1-3.4-6.1-8c0-5.5,3.2-9.1,8-9.1c2.4,0,3.9,0.7,4.6,1.9c0.4,0.8,0.5,1.3,0.5,3L231.7,47.8z%20M200.4,30.7c-6.5,0-11.8,5.6-11.8,12.5c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C212.1,36.3,206.8,30.7,200.4,30.7%20M200.4,52c-4,0-7.2-3.9-7.2-8.8s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S204.4,52,200.4,52%20M175.3,30.7c-6.5,0-11.8,5.6-11.8,12.5%20c0,6.8,5.4,12.5,11.8,12.5c6.3,0,11.7-5.7,11.7-12.5C187,36.3,181.7,30.7,175.3,30.7%20M175.3,52c-4.1,0-7.2-3.9-7.2-8.8%20s3.2-8.8,7.2-8.8c4,0,7.2,3.9,7.2,8.8S179.3,52,175.3,52%20M123.1,30.7c-2.3,0-4.6,0.9-6.4,2.4c-1.1,0.9-2.1,1.9-3,2.9v-4.7h-4.2%20v23.8h4.2V40.7c4-4.5,6.5-6.2,8.9-6.2c0.9-0.1,1.8,0.4,2.3,1.2c0.3,0.9,0.4,1.8,0.3,2.7v16.8h4.2V37.4%20C129.5,32.9,127.4,30.7,123.1,30.7%20M160.5,31.3c0,0-5.6,18-5.8,18.5c-0.8-2.4-6.1-18.4-6.1-18.4l0-0.1h-4.4c0,0,1.6,4.1,1.6,4.2%20c0,0.1-5,13.8-5.2,14.3c-0.7-2.3-5.6-18.5-5.6-18.5l0-0.1h-4.6l7.9,24.4h3.5l5.6-14.8c0,0,0.1-0.4,0.2-0.8l0.2,0.8%20c0,0,5.3,14.8,5.3,14.8h3.4l8.2-24.4L160.5,31.3z'/%3e%3cpath%20id='Path_2'%20class='st2'%20d='M24.2,55.1c0.2-6.8-1.5-13.5-4.9-19.4C15.8,29.7,10.8,24.6,4.8,21c-0.2,6.8,1.5,13.5,4.9,19.4%20C13.1,46.5,18.2,51.5,24.2,55.1'/%3e%3cpath%20id='Path_3'%20class='st3'%20d='M30.9,56.6c2.2-9.5,1.8-19.4-1.3-28.6c-3.2-9.4-8.8-17.8-16.3-24.4c-2.2,9.5-1.8,19.4,1.3,28.6%20C17.8,41.6,23.4,50,30.9,56.6'/%3e%3cpath%20id='Path_4'%20class='st4'%20d='M38.7,55.1c5.8-5.1,10.1-11.7,12.5-19c2.3-7.2,2.6-14.9,0.8-22.2c-5.8,5.1-10.1,11.7-12.5,19%20C37.2,40.1,36.9,47.8,38.7,55.1'/%3e%3cpath%20id='Path_5'%20class='st5'%20d='M242.6,23.6c-1.9,0-3.4-1.5-3.4-3.4c0-1.9,1.5-3.4,3.4-3.4c1.9,0,3.4,1.5,3.4,3.4%20C246,22,244.5,23.6,242.6,23.6%20M242.6,17.3c-1.6,0-2.9,1.3-2.9,2.9s1.3,2.9,2.9,2.9c1.6,0,2.9-1.3,2.9-2.9c0,0,0,0,0,0%20C245.5,18.6,244.2,17.3,242.6,17.3%20M243.5,22.1l-1.2-1.6h-0.4v1.6h-0.7v-3.9h1.4c1,0,1.5,0.3,1.5,1.1c0,0.6-0.4,1.1-1,1.1%20c0,0,0,0,0,0l1.3,1.7L243.5,22.1z%20M243.1,18.8c-0.2-0.1-0.4-0.1-0.6-0.1h-0.6V20h0.6c0.6,0,0.9-0.2,0.9-0.7%20C243.4,19.1,243.3,18.9,243.1,18.8'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Board seats come from each company's latest proxy statement.
Experience
- Ironwood PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -70%
- Octave Health Group Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?